Cargando…
克唑替尼治疗ALK阳性晚期非小细胞肺癌患者的疗效观察
BACKGROUND AND OBJECTIVE: The aim of this study is to explore clinical efficacy of crizotinib in advanced anaplastic lymphoma kinase (ALK) positive non-small cell lung cancer. METHODS: Twenty-eight patients with advanced non-small cell lung cancer habouring ALK positive were randomly divided into cr...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
中国肺癌杂志编辑部
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6000091/ https://www.ncbi.nlm.nih.gov/pubmed/26483333 http://dx.doi.org/10.3779/j.issn.1009-3419.2015.10.03 |